Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
종목 코드 XTNT
회사 이름Xtant Medical Holdings Inc
상장일Jun 30, 2010
CEOMr. Sean E. Browne
직원 수217
유형Ordinary Share
회계 연도 종료Jun 30
주소664 Cruiser Lane
도시BELGRADE
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호59714
전화14063880480
웹사이트https://xtantmedical.com/
종목 코드 XTNT
상장일Jun 30, 2010
CEOMr. Sean E. Browne
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음